Lanean...
cMyBPC phosphorylation modulates the effect of omecamtiv mecarbil on myocardial force generation
Omecamtiv mecarbil (OM), a direct myosin motor activator, is currently being tested as a therapeutic replacement for conventional inotropes in heart failure (HF) patients. It is known that HF patients exhibit dysregulated β-adrenergic signaling and decreased cardiac myosin-binding protein C (cMyBPC)...
Gorde:
| Argitaratua izan da: | J Gen Physiol |
|---|---|
| Egile Nagusiak: | , , , , , |
| Formatua: | Artigo |
| Hizkuntza: | Inglês |
| Argitaratua: |
Rockefeller University Press
2021
|
| Gaiak: | |
| Sarrera elektronikoa: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7953254/ https://ncbi.nlm.nih.gov/pubmed/33688929 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1085/jgp.202012816 |
| Etiketak: |
Etiketa erantsi
Etiketarik gabe, Izan zaitez lehena erregistro honi etiketa jartzen!
|